The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 20, 2019

Filed:

Jan. 19, 2017
Applicant:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Inventors:

Jeffrey D. Lee, New York, NY (US);

Alexander O. Mujica, Elmsford, NY (US);

Wojtek Auerbach, Ridgewood, NJ (US);

Ka-Man Venus Lai, Tarrytown, NY (US);

David M. Valenzuela, Yorktown Heights, NY (US);

George D. Yancopoulos, Yorktown Heights, NY (US);

Assignee:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/85 (2006.01); A61D 19/04 (2006.01); A01K 67/027 (2006.01); C07K 14/715 (2006.01); C07K 14/775 (2006.01); C12N 15/90 (2006.01);
U.S. Cl.
CPC ...
C12N 15/8509 (2013.01); A01K 67/0276 (2013.01); A01K 67/0278 (2013.01); A61D 19/04 (2013.01); C07K 14/7155 (2013.01); C07K 14/775 (2013.01); C12N 15/907 (2013.01); A01K 2217/07 (2013.01); A01K 2227/105 (2013.01); A01K 2267/0362 (2013.01); A01K 2267/0381 (2013.01); C12N 2015/8527 (2013.01); C12N 2800/30 (2013.01); C12N 2810/00 (2013.01);
Abstract

Compositions and methods are provided for modifying a rat genomic locus of interest using a large targeting vector (LTVEC) comprising various endogenous or exogenous nucleic acid sequences as described herein. Compositions and methods for generating a genetically modified rat comprising one or more targeted genetic modifications in their germline are also provided. Compositions and methods are provided which comprise a genetically modified rat or rat cell comprising a targeted genetic modification in the rat interleukin-2 receptor gamma locus, the rat ApoE locus, the rat Rag2 locus, the rat Rag1 locus and/or the rat Rag2/Rag1 locus. The various methods and compositions provided herein allows for these modified loci to be transmitted through the germline.


Find Patent Forward Citations

Loading…